ARS Pharmaceuticals, Inc. (SPRY)
4.295
-0.26
(-5.81%)
USD |
NASDAQ |
Oct 09, 14:59
ARS Pharmaceuticals Net Income (Quarterly) : -62.34M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -62.34M |
| March 31, 2026 | -60.62M |
| December 31, 2025 | -41.32M |
| September 30, 2025 | -51.15M |
| June 30, 2025 | -44.88M |
| March 31, 2025 | -33.94M |
| December 31, 2024 | 49.93M |
| September 30, 2024 | -19.13M |
| June 30, 2024 | -12.52M |
| March 31, 2024 | -10.29M |
| December 31, 2023 | -7.168M |
| September 30, 2023 | -14.87M |
| June 30, 2023 | -17.37M |
| March 31, 2023 | -14.96M |
| Date | Value |
|---|---|
| December 31, 2022 | 27.24M |
| September 30, 2022 | -6.583M |
| June 30, 2022 | -6.42M |
| March 31, 2022 | -7.25M |
| December 31, 2021 | -23.46M |
| September 30, 2021 | -22.66M |
| June 30, 2021 | -24.50M |
| March 31, 2021 | -18.87M |
| December 31, 2020 | -13.08M |
| September 30, 2020 | -8.116M |
| June 30, 2020 | -6.467M |
| March 31, 2020 | -5.279M |
| December 31, 2019 | -6.97M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | -40.73M |
| Sionna Therapeutics, Inc. | -29.89M |
| Nektar Therapeutics | -40.62M |
| Vertex Pharmaceuticals, Inc. | 1.100B |
| Ardelyx, Inc. | -16.72M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 33.66M |
| Total Expenses (Quarterly) | 96.00M |
| EPS Diluted (Quarterly) | -0.6277 |
| Enterprise Value | 406.27M |
| Gross Profit Margin (Quarterly) | 61.83% |
| Profit Margin (Quarterly) | -185.2% |
| Earnings Yield | -50.60% |
| Normalized Earnings Yield | -50.61 |